ArticleGynecologic oncology2018
Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer.
Anil Belur Nagaraj et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticleGynecologic oncology2018
Anil Belur Nagaraj et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.